Valentim Gonçalves, A.; Pereira-da-Silva, T.; Galrinho, A.; Rio, P.; Moura Branco, L.; Soares, R.; Feliciano, J.; Ilhão Moreira, R.; Cruz Ferreira, R.
Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement? J. Clin. Med. 2019, 8, 869.
https://doi.org/10.3390/jcm8060869
AMA Style
Valentim Gonçalves A, Pereira-da-Silva T, Galrinho A, Rio P, Moura Branco L, Soares R, Feliciano J, Ilhão Moreira R, Cruz Ferreira R.
Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement? Journal of Clinical Medicine. 2019; 8(6):869.
https://doi.org/10.3390/jcm8060869
Chicago/Turabian Style
Valentim Gonçalves, António, Tiago Pereira-da-Silva, Ana Galrinho, Pedro Rio, Luísa Moura Branco, Rui Soares, Joana Feliciano, Rita Ilhão Moreira, and Rui Cruz Ferreira.
2019. "Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?" Journal of Clinical Medicine 8, no. 6: 869.
https://doi.org/10.3390/jcm8060869
APA Style
Valentim Gonçalves, A., Pereira-da-Silva, T., Galrinho, A., Rio, P., Moura Branco, L., Soares, R., Feliciano, J., Ilhão Moreira, R., & Cruz Ferreira, R.
(2019). Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement? Journal of Clinical Medicine, 8(6), 869.
https://doi.org/10.3390/jcm8060869